Shizane's Accounts

Sticky

Shizane

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

Shizane

09/23/13 4:48 PM

Post #66

Re: #56: @Shizane - UPDATE: iBox - 09/09/13

UPDATE: 09/23/13

Updated the current share prices on the Stock Watchlist.

Shizane

09/23/13 4:38 PM

Post #65

PURCHASE: IGXT

I purchased 1,000 shares of IGXT at .57 today.

Yes the stock is an OTC stock but it has a PDUFA date of February 3, 2013. Also the S-1 should be closed within the next week.

Shizane

09/23/13 4:36 PM

Post #64

Re: #63: @Shizane - PURCHASE: ETRM

SOLD: ETRM

Sold ETRM at $1.23 from $1.20 entry.

The stock has been trading in a narrow range and I should having taken gains when it was trading in the $1.30's.

Shizane

09/23/13 2:32 PM

Post #63

PURCHASE: ETRM

I purchased ETRM at a Cost Basis of $1.20 on 09/16/13.

Should be hearing about a possible ADCOM in the coming weeks.

Shizane

09/23/13 2:30 PM

Post #62

SELL: PBMD

I sold PBMD @ $2.38 on 09/13/13 for an over 5% loss.

I have been unable to update the iHub Board; I will update more often.

Shizane

09/12/13 4:21 PM

Post #61

Re: #38: @Shizane - PRUCHASE: PBMD

PURCHASE: PBMD

Purchased PBMD @ 2.345 for a combined Cost Basis of 2.40.

I believe the stock should turn north soon. Result from CAN-103 is to be released on October 01, 2013.

Shizane

09/12/13 4:04 PM

Post #60

Re: #49: @Shizane - PURCHASE: NVAX

SOLD: NVAX

Sold NVAX at $3.36 for a 2.36% gain will keep an eye on the stock as in nears the "Analyst Day" on September 24, 2013.

Shizane

09/11/13 8:56 AM

Post #59

NEWS: NVAX - Currently Holding (updated)

These presentations reflect our progress in defining the importance of the palivizumab-like antibody and confirm that the RSV F vaccine induces promising immune responses in the elderly population.

These two studies are important because they demonstrate the potential of our vaccine candidate to prevent a major public health problem in the elderly and also provide protection to infants through passive maternal immunization. These are critical unmet needs which we plan to address in later-stage efficacy studies.

>Gregory Glenn, M.D., Senior Vice President and Chief Medical Officer of Novavax

ICAAC Presentations Highlight Potential Protective Effects of Novavax’ RSV Vaccine Candidate

Presentations:
RSV F Protein Vaccine is Well-Tolerated and Immunogenic in Elders

Passive Immunization with RSV F Vaccine-Induced Polyclonal Antibodies Protect Cotton Rats From RSV A Challenge

Shizane

09/09/13 5:40 PM

Post #58

Re: #57: @Shizane - NVAX - Currently Holding

NVAX - Currently Holding

Link for Novavax, Inc. Wedbush 2013 Life Sciences Management Access presentation on August 13, 2013 by president and CEO Stanley C. Erck.

NVAX Wedbush Presentation

Shizane

09/09/13 4:42 PM

Post #57

Re: #49: @Shizane - PURCHASE: NVAX

NVAX - Currently Holding

Novavax, Inc. has a very interesting week.

Beginning on Wednesday, September 11, 2013 NVAX will present at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Denver, Colorado the session, entitled “RSV F Protein Vaccine Is Well-Tolerated and Immunogenic in Elders,” will present data from the company’s recently completed Phase 1 clinical trial of its RSV vaccine candidate in healthy elderly adults. Also, on the 11th “Passive Immunization with RSV F Vaccine-Induced Polyclonal Antibodies Protect Cotton Rats from RSV A Challenge" will be presented, both sessions are scheduled to be presented from 11:00AM - 01:00PM.

Then on Thursday, September 12, 2013 President and CEO of NVAX Stanley C. Erck will present at the Stifel Nicolaus Healthcare Conference 2013 in Boston, Massachusetts @ 09:45AM.

Links for more information on the presentations.
Novavax, Inc. Events

Shizane

09/09/13 4:01 PM

Post #56

Re: #53: @Shizane - UPDATE: 09/05/13

UPDATE: iBox - 09/09/13

Updated the Stock Watchlist with current 10-day moving average volumes and prices.

Shizane

09/05/13 9:15 AM

Post #55

NEWS: CHTP

CHTP price target raised to $4.00 from $3.50 with a "buy" rating at Ladenburg Thalmann.

Shizane

09/05/13 8:59 AM

Post #54

Re: #52: @Shizane - NEWS: APPY, RIGL

NEWS: NSTG, CGIX, TRGT, CEMI

NSTG

New Workflow to Provide Scientists with Tools That Enable Single Cell Analysis for Oncology, Immunology and Stem Cell Research

CGIX

Cancer Genetics, Inc. [CGIX] to Ring The NASDAQ Stock Market Opening Bell

Cancer Genetics Announces Exercise of Underwriters' Over-Allotment Option

TRGT

Targacept to Present at the Stifel Healthcare Conference 2013

CEMI

Form 8-K for CHEMBIO DIAGNOSTICS, INC.

Shizane

09/05/13 8:12 AM

Post #53

Re: #45: @Shizane - UPDATE: iBox - 09/01/13

UPDATE: 09/05/13

Updated the Stock Watchlist Current Prices

Shizane

09/05/13 8:09 AM

Post #52

NEWS: APPY, RIGL

APPY

APPY Income Statement

Venaxis to Present at Three Upcoming Investor Conferences

RIGL

Rigel To Focus On ITP, DLE And Dry Eye

Shizane

09/04/13 2:58 PM

Post #51

INFO: BioTech

Drug firms and cancer: Lucrative lifesavers

Shizane

09/03/13 11:10 AM

Post #49

PURCHASE: NVAX

Added to a position in NVAX this morning at a Cost Basis of 3.30 a share for a combined Cost Basis of 3.25 a share for total NVAX holdings.

Shizane

09/03/13 10:05 AM

Post #48

SOLD: MSTX

I sold the remaining MSTX shares I had at .4201 for a slight loss.

Shizane

09/03/13 9:11 AM

Post #47

INFO: BioTech

It's No Accident That Drugs Are Expensive

Shizane

09/03/13 9:06 AM

Post #46

NEWS: NVAX

NVAX
Novavax to Present RSV Vaccine Clinical and Preclinical Results at ICAAC

Shizane

09/01/13 11:57 AM

Post #45

UPDATE: iBox - 09/01/13

Updated the portfolio balance for America, also updated the Stock Watchlist with current 10-day moving average volume and prices.

Shizane

08/30/13 3:27 PM

Post #44

PURCHASE: NVAX

I bought NVAX at a Cost Basis of 3.23. The company has a last minute presentation scheduled for September 12, 2013. The company must have some important information to release, so the stock should appreciate until then.

Genocea Biosciences Selected To Present Late-Breaking Oral Presentation At ICAAC 2013

Shizane

08/30/13 3:22 PM

Post #43

SOLD: ZLCS

I sold today at .7114 from my .65 entry for a 7.19% gain. Stock has had a lot of volume recently, but the three day weekend and the uncertainty of a R/S made me take my profits.

Shizane

08/30/13 9:49 AM

Post #42

Re: #41: @Shizane - ZLCS - Currently Holding

ZLCS - Currently Holding

The stock is moving up again today; trading at .711 or up .038 (5.65%) from yesterday.

The volume is also over half of the 10-day moving average of volume in just 20 minutes of trading.

Shizane

08/29/13 4:06 PM

Post #41

Re: #39: @Shizane - ZLCS - Currently Holding

ZLCS - Currently Holding

The stock had a good day, finishing up .0329 or 5.14% on nearly two times the 10-day moving average of volume.

It will be interesting to see where the stock ends up tomorrow before the three-day Labor Day weekend.

Shizane

08/29/13 4:03 PM

Post #40

UPDATE: iBox - 08/29/13

Updated the Stock Watchlist current prices

Shizane

08/29/13 12:06 PM

Post #39

Re: #37: @Shizane - PURCHASE: ZLCS

ZLCS - Currently Holding

The volume has increase today. The volume is around the 10-day moving volume average with 4 hours left in trading. The share price is currently up .0399 for today and .03 since my purchase yesterday at a Cost Basis of .65.

Shizane

08/29/13 12:03 PM

Post #38

PRUCHASE: PBMD

Purchased PBMD at a Cost Basis of 2.51. The company has an October 1, 2013 catalyst. The company just did a $60mm shelf.

Shizane

08/28/13 4:09 PM

Post #37

PURCHASE: ZLCS

I purchased ZLCS at a Cost Basis of .65

The company will release information on Z160 towards the end of October.

The company also may do a reverse split if the stock price does not rise above $1 for ten days straight before October 21 to comply with the NASDAQ $1 minimum bid price. The stockholders have approved both a 1 for 5 and a 1 for 10 split.

Here is a Seeking Alpha article for quick information on ZLCS.
For Zalicus, Z160 Data In October Could Be Huge

Shizane

08/28/13 4:06 PM

Post #36

UPDATE: iBox - 08/28/13 Afternoon

Updated the Stock Watchlist current prices

Shizane

08/28/13 10:15 AM

Post #35

SOLD: MSTX

Sold 2/3 for a 2.91% gain. Holding a core to see what happens in the coming days.

Shizane

08/28/13 8:03 AM

Post #34

NEWS: MACK

MACK

Merrimack Reaches Patient Enrollment Goal in the Phase 3 NAPOLI-1 Study of MM-398 in Late Stage Pancreatic Cancer

Shizane

08/28/13 7:56 AM

Post #33

UPDATE: iBox - 08/28/13

Updated the Stock Watchlist current prices

Shizane

08/28/13 7:25 AM

Post #32

NEWS: ASTX, HZNP

ASTX

Astex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study

HZNP

Horizon Pharma files patent infringement lawsuit against Watson Laboratories

Shizane

08/27/13 8:54 AM

Post #31

NEWS: AKRX, HITK, OREX, SRDX, CNDO, ABBV, QCOR

AKRX, HITK

Akorn Agrees to Purchase Hi-Tech Pharmacal for $640 Million

OREX

Orexigen Therapeutics Prepares for the Light Study Interim Analysis Based on Direction from Data Monitoring Committee

SRDX

SurModics to Present at CL King’s Best Ideas Conference

CNDO

Coronado Biosciences to Participate in Citi's 8th Annual Biotech Conference

ABBV

AbbVie to Present at Morgan Stanley Global Healthcare Conference

QCOR

Questcor Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

Shizane

08/27/13 8:40 AM

Post #30

NEWS: CPRX

CPRX - the stock is rocketing today, missed out on this one as I sold it for a loss last week.

Catalyst Pharmaceutical Partners Receives Breakthrough Therapy Designation From FDA for Firdapse(TM) for the Treatment of LEMS

Shizane

08/26/13 4:32 PM

Post #29

MSTX - Currently Holding

MSTX had an interesting day. The stock finished up .015 or 3.57% on 1,766,131 in volume; close to three times the 10-day moving average. Sometimes where there is an increase in volume there could be an increase in share price.

Shizane

08/26/13 4:29 PM

Post #28

UPDATE: iBox - 08/26/13

Updated the Stock Watchlist current prices.

Shizane

08/26/13 1:45 PM

Post #27

CLSN - The company will announce HEAT study results 09/14/13. The stock price could have a run up to the announcement. I will watch this one and look at a possible entry.

Celsion Announces Official ThermoDox® HEAT Study Results to be presented at the International Liver Cancer Association (ILCA) 2013 Annual Conference in Washington, D.C. on September 14, 2013

Shizane

08/26/13 12:15 PM

Post #26

MSTX - Currently holding

The stock is looking good today; it is up 6.88% to .4489 with over 1,300,000 shares traded - far above the 668,523 10-day moving average of volume. There is still over 3 1/2 hours left in trading so it could be telling where the stock ends up at 4PM.

***Edit

The RSI on the hourly chart has just dropped below overbought and the MACD line has crossed over the signal to the positive, meaning appreciation could be in the works.

The RSI on the daily is a little over half way between the overbought and oversold lines - meaning accumulation is happening but not at a rate to be worried about; and, the MACD line is about to cross the signal if this happens the stock might move up even more.

Shizane

08/26/13 9:20 AM

Post #25

NEWS: CXM, NVO, FCSC

CXM

Cardium's LifeAgain Announces Commercialization Agreement With AgencyONE Based On Advanced Medical Data Analytics Platform Technology

NVO

On 8 August 2013, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules. This programme is part of the overall share repurchase programme of up to DKK 14.0 billion to be executed during a 12-month period beginning 31 January 2013.

Company Announcement No 57 2013: http://hugin.info/2013/R/1724840/575019.pdf

FCSC

Fibrocell Science Appoints Greg Weaver Chief Financial Officer, Senior Vice President, Treasurer and Corporate Secretary

Shizane

08/26/13 8:24 AM

Post #24

NEWS: OGEN, NEPT, HEB, PTCT, LIFE, Q

OGEN

Oragenics Collaboration Demonstrates Initial Success in the Second Phase of Lantibiotics Project

NEPT

Neptune Receives Additional $5 Million Insurance Payment

HEB

Hemispherx Announces Biosecurity Program to Potentially Reduce Pandemic Influenza Threat

PTCT

New Evidence Published in Muscle and Nerve on Measuring 6-Minute Walk Distance in Duchenne Muscular Dystrophy

LIFE

Life Technologies Expands Food Testing Portfolio to Global Brewing and Beverage Industry

Q

Quintiles Infosario Receives Computerworld Data+ Editor’s Choice Award

Shizane

08/26/13 7:50 AM

Post #23

NEWS: RIGL

RIGL

Rigel's R343 Did Not Meet Primary Endpoint in Asthma Study

Shizane

08/26/13 7:09 AM

Post #22

NEWS: CGEN, CBRX, AMRN, RGDX, ADHD

CGEN

Compugen Establishes Scientific Advisory Board to Guide Pipeline Program Development

CBRX

Columbia Laboratories regains compliance with Nasdaq

AMRN

Amarin Announces Submission of Supplemental New Drug Application for Novasep as Fourth Vascepa(R) Active Pharmaceutical Ingredient Supplier

RGDX

Response Genetics, Inc. Acquires Proprietary FDA-Cleared and Medicare-Reimbursed Test and All Associated Assets for Difficult to Diagnose Solid Tumors

ADHD

Alcobra Enrolls First Patient in Comparative Study of Executive Function Benefits in Patients With PI-ADHD

Shizane

08/25/13 6:14 PM

Post #21

Update: iBox

I just updated the iBox with current info. I plan on doing this every weekend, to keep the information up to date.

Shizane

08/25/13 6:02 PM

Post #20

NEWS: AMGN ONXX

AMGN ONXX

Amgen Strikes $10.4 Billion Deal for Onyx

Shizane

08/23/13 11:21 AM

Post #19

MSTX - great volume today - 718,757 shares traded compared to the 10 day average of 652,198. And there's still 4 1/2 hours left in trading.

Shizane

08/22/13 10:02 AM

Post #18

Re: #16: @Shizane - NEWS: CPRX

Looks like CPRX will fall today with the warrants being exercised

Shizane

08/22/13 9:38 AM

Post #17

NEWS: ATOS

ATOS

Atossa Genetics to Ring the NASDAQ Stock Market Closing Bell in Celebration of Recent Listing on NASDAQ Stock Market

Shizane

08/22/13 9:06 AM

Post #16

Re: #15: @Shizane - NEWS: NAVB. OMED, REGN, GHDX, SNTS, AVNR, VRTX, CYTK

NEWS: CPRX

Catalyst receives $1.07M from exercise of warrants • 8:59 AM

Catalyst Pharmaceutical (CPRX) has received $1.07M from the exercise of stock warrants to buy 1.03M shares.

The company issued the warrants in its IPO in May last year.

Catalyst doesn't appear to have provided any further details in the 8-K disclosing the news.

The amount received indicates a price of $1.04 a share vs yesterday's close of $1.31.

Older

Shizane's Accounts

Followers	1	Posters	2
Posts (Today)	0	Posts (Total)	66
Created	08/15/13	Type	Premium
Moderators

Welcome to Shizane's Accounts

This page is to track my success and failures (hopefully fewer of the latter). I tend to hold on to stocks for weeks while also looking to trade for a quick profit. I will be as transparent as I can be in buys and sells and reasons for doing both. I will list my current / past holdings in a chart.

America is a newer account I have had since 2013.

Speculative Plays is an account I have created in 2014.
This account was initally funded with the proceeds of my mother giving me 206 shares of PepCo Holdings (POM). Since she nor I had to use any of our own money for this account, this account is going to be a more specualtive play account.

I invest mostly in Bio-Techs under $10.00.

NO OTC STOCKS

***I also reserve the right to buy or sell at anytime I want***

America Portfolio

Current / Past Holdings
TICKER	Reason for Purchase	Cost Basis	Purchase Date	Purchase Average Volume (10 day)	Sell Price	Sell Date	Gain / Loss (%)
MSTX	Catalyst Play Through 2013	.42189	08/15/13	358,019	2/3 @ .431 1/3@.4201	08/28/13 09/03/13	2.91 .02 = 1.93
ZLCS	October readout of data / possible reverse split	.65	08/28/13	1,490,229	.7114	08/30/13	7.19
NVAX	September 11, 2013 presentation @ICAA. September 12, 2013 presentaion @ Stifel Nicolaus September 24, 2013 annual "Analyst Meeting." $11 price target from Lazard.	3.23 3.30 = 3.25	08/30/13 09/03/13	4,173,193	3.36	09/12/13	2.36
ETRM	Should be hearing about a possible ADCOM soon.	1.20	09/16/13	700,000	1.23	09/23/13	2.5

***Liinks over the ticker will take you to the company's website***

Speculative Plays

Current / Past Holdings
Ticker	Reason for Purchase	Cost Basis	Purchase Date	Purchase Average Volume (10-day)	Sell Price	Sell Date	Gain / Loss (%)

***Liinks over the ticker will take you to the company's website***

Stock Watchlist
TICKER	Reasons	First Observed Date	First Observed Price	Current Price*	First Observed Average Volume (10 day)	Current Average Volume (10 day)	Notes:

*Updated Daily

**Updated Weekly - increase in volume could indicate an increase in share price.
   - Indicates higher than first observed
  - Indicates lower than first observed
  - Indicates currently in portfolio

Indecies

Dow Nasdaq S&P500

Helpful Links

BioPharm Catalyst

(Calendar of AdCom meetings and PDUFAs)

Clincal Trials

(Type in company name to review all past and current trails)

Investopedia

(Type in anything you have a question about)

$heff's Station

(I follow this board and place a lot of my trades on the advice found here)

Yahoo! BioTech

(News relating to the BioTech Industry)

Post Labels and Descriptions
Label	Description
Info	Article and / or information on the topic listed
News	News release on the ticker(s) mention
Purchase	Bought a position in mention ticker
Sold	Sold out of a postition in mention ticker
Ticker	Update(s) and Insight(s) on stated ticker
Update	Updates made to the iBox

Thanks for looking at the board if you have any questions or comments just write on the board or send me a private message!

Board Info

Posts Today	0
Posts (Total)	66
Posters	2
Moderators

New Post

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Shizane's Accounts

Shizane's Accounts

Join the InvestorsHub Community

Shizane's Accounts

Board Info